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The aim of the research is to quantify the effect of smoking on mortality condi-
tions in one and a half decades after the turn of the millennium. However, this is not 
the first such an attempt in our country. The study of Péter Józan and László Radnóti 
that was published under the title “The impact of smoking on mortality in Hungary 
1970–1999” (KSH [2002]) can be regarded as a pioneering work in the topic. Ten 
years later, József Vitrai and his co-authors published their analysis paper “The so-
cial burdens of smoking in Hungary” (Vitrai et al. [2012]). Afterwards, as a part of a 
periodical publication of the Hungarian Central Statistical Office, a study of András 
Wéber and Miklós Faragó on the impact of nicotine dependence on mortality was 
published (KSH [2014]). All the three studies applied the CDC-recommended proce-
dure for the Hungarian conditions. The present study does not depart from this meth-
odological recommendation either, but compared with the earlier ones, it uses its 
updated version (U.S. HHS CDC NCCDPHP Office on Smoking and Health [2014]) 
containing the results of the latest research.  
In Hungary, the level of mortality is high compared not only with the Western 
European but also with the Visegrád countries, and within this, tobacco consumption 
is also a determining factor. Lifestyle factors have a decisive impact on the health of 
an individual, and smoking as a risk factor greatly damages the chances of life. This 
relationship was confirmed by Sir Richard Doll (an English epidemiologist who was 
the first to prove in the 1950s that nicotine addiction causes an increased risk of lung 
cancer and heart disease) and A. Bradford Hill (Doll–Hill [1950]). According to the 
recent research, the health-damaging effect of smoking is general and can be detect-
ed in the entire human body. Consequently, this addiction has a decisive role in the 
development of more than one, mostly chronic diseases leading to death.  
Nor can we forget about the socio-economic costs of smoking. On the revenue 
side, there is a predictable and steady budgetary source in the form of excise tax and 
VAT. In contrast, on the expenditure side, there are the costs of curing tobacco-
related diseases (such as medicines, inpatient care), extra expenditures on health and 
social systems (sick pay, disability retirement, etc.) and the loss of deceased active 
women and men. After examining the balance of the total smoking-related individual 
and state expenditures and revenues, Vitrai et al. ([2012] p. 9.) estimated a nearly 
HUF 80 billion (!) loss in 2010.  
Having regard to the above, all measures that are aimed at reducing the prevalence 
of smoking and promoting the prevention of this addiction are therefore justified, as 
additional deaths caused by nicotine addiction can be prevented (Vokó [2009]). Appro-
priate steps in this direction were the enactment of a ban on 1 January 2012 on smok-
ing in closed public spaces and the increase of excise duties on tobacco products.  
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Using descriptive statistical tools, the present study examines the phenomenon 
and basic trends of smoking-attributable excess mortality in Hungary by the varia-
bles of gender, age and causes of death from the turn of the millennium to the present 
day. In addition, an international outlook relying on the WHO-HFA database is also 
presented to introduce the situation in the neighbouring countries. The research pri-
marily seeks to follow the goal of earlier works: “so that we can measure the results 
achieved in reducing this addiction” (KSH [2002] p. 9.). 
1.  Prevalence of smoking1 
The precondition of calculating smoking-attributable excess mortality is to know 
prevalence of smoking. In the period observed by the research, the similarity of the 
data of four representative surveys (the National Health Interview Survey 2000, 2003 
and the European Health Interview Survey 2009, 2014) allows the combined use of 
results (Vitrai et al. [2012]). Based on these surveys, the population of Hungary can 
be divided into three parts: current smokers, those who have quit smoking and who 
never smoked. Since prevalence is one of the bases for calculating smoking-
attributable mortality, its examination by gender and age is justified. 
As indicated by the above health interview surveys, one in every two men and 
every third woman in Hungary is affected by nicotine dependence. According to the 
estimates of the questionnaire-based research, the absolute number of men who cur-
rently smoke or have quit smoking was more than 2.5 million at the turn of the mil-
lennium, but it fell to about 2.2 million by 2014. For women, the decline was lower: 
their corresponding figures were 1.75 million and around 1.65 million, respectively. 
This means that over one and a half decades, the base population of smoking-
attributable mortality decreased in the case of both sexes.   
As a result, about 1.3 million men smoked according to the health interview survey 
in 2014, and the relevant figure for women remained steadily below 1 million. If we 
examine the estimates for smoking status with 95% confidence intervals by age group, 
a significant decrease can be seen among 40–44-year-old men in 2014 compared with 
2000. Regarding the prevalence of smoking among women, a decline occurred in a 
wider age group, between 30 and 45 years of age. In contrast, the proportion of nico-
tine addicts among women aged 55–65 years has increased significantly since the turn 
of the millennium. Another unfavourable development is that there has been no de-
crease in the prevalence of smoking in the 18–30-year-old population since 2000. 
 
1 The proportion (frequency of occurrence) of individuals (in this case smokers) suffering from a certain 
disease in the total population.  
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Figure 1. Prevalence of smoking by gender and age group, 2000 and 2014 
(with 95% confidence intervals) 
                                            Men                                                                                     Women 
Percent                                                                              Percent 
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Source: Here and in the following figures and tables, own calculations. 
Figure 2. Prevalence of non-smoking by gender and age group, 2000 and 2014 
(with 95% confidence intervals) 
                                            Men                                                                                     Women 
Percent                                                                              Percent 
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In line with the findings, non-smoking became significantly more common 
among 40–50-year-old men between 2000 and 2014. In parallel, the ratio of non-
smoking women aged 30–45 years in the female population also rose considerably, 
while the proportion of those who never smoked fell remarkably among older wom-
en aged 50–70 years. 
In the case of those who have quit smoking, significant changes could only be ob-
served in the female population during the observed period. In the prevalence of 
smoking among such women, there has been a slight reduction around the age of 40 
and an increase in the 60–65 age group.   
Figure 3. Prevalence of ex-smoking by gender and age group, 2000 and 2014 
(with 95% confidence intervals) 
                                            Men                                                                                     Women 
Percent                                                                             Percent 
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2. Smoking-attributable mortality 
“By the definition, »smoking-attributable mortality due to a certain cause of 
death« in a population means that how many persons would not have died out of 
those suffering from the given cause of death if their death rate had equalled the one 
of non-smokers.” (KSH [2014] p. 30.) Based on CDC instructions, the research relies 
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on three data sources: 1. relative risks, 2. smoking prevalence and 3. the number of 
deaths due to certain causes of death.   
Relative risks quantify the health risks of tobacco use among smokers and ex-
smokers compared with non-smokers. These measures are known by group of dis-
eases as well. For example, according to the methodology updated in 2013, the 
chances of a 65–74-year-old smoking man to die of lung cancer is more than 28-fold 
compared with a non-smoking man. Accordingly, the relative risk for non-smokers is 
always 1. In general, these multipliers are lower for women, ex-smokers and for 
younger age groups. Due to the slow progression of smoking-associated diseases and 
the fact that addiction usually begins when people are in their teens, the methodology 
assumes that no one dies from diseases caused by nicotine addiction before the age 
of 35. (Smoking may cause infrequently fatal accidents as well, but their number is 
insignificant.) The few – fortunately very rare – exceptions are those cases when an 
infant death occurs due to the mother’s smoking during pregnancy. 
Smoking prevalence rates for the Hungarian population are known from the health 
interview surveys (NHIS 2000, NHIS 2003, EHIS 2009, EHIS 2014) for the period 
between 2000 and 2014. For intermediate years, a statistical approximation method 
was applied. The number of deaths due to certain smoking-associated causes of death 
by age group is available from the causes of death database of the Hungarian Central 
Statistical Office. The calculations resulted in the numbers of smoking-attributable 
excess deaths by cause of death, gender and 5-year age group between 2000 and 2014.  
Generally, approximately one in every five deceased persons dies because of 
smoking every year in Hungary. During the observed one and a half decades, the 
absolute number of deaths associated with nicotine dependence stagnated around 
25 thousand. As a result of the decline in overall mortality and the stagnation of the 
absolute number of persons died as a result of addiction, the proportion of smoking-
attributable mortality within the total number of deaths slightly increased in the ex-
amined period. However, the standardised death rate that eliminates the impact of the 
different age structure of the Hungarian population compared with that of the Euro-
pean population decreased by nearly 14% between 2000 and 2014. 
Table 1 
Number of smoking-attributable excess deaths, their proportion within total mortality  
and smoking-attributable standardised death rate per 100 000 persons, 2000–2014 
Year 
Number of smoking-
attributable deaths 
Smoking-attributable standardised 
death rate per 100 000 persons* 
Percentage of smoking-attributable 
deaths within total mortality 
2000 24 816 297.48 18.30 
(20 353–31 168) (236.22–391.86) (15.01–22.99) 
(Continued on the next page) 
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(Continuation) 
Year 
Number of smoking-
attributable deaths 
Smoking-attributable standardised 
death rate per 100 000 persons* 
Percentage of smoking-attributable 
deaths within total mortality 
2001 24 093 286.01 18.23 
(19 675–30 424) (226.25–379.77) (14.88–23.02) 
2002 24 258 286.59 18.26 
(19 704–30 855) (225.09–385.45) (14.83–23.23) 
2003 25 040 293.50 18.44 
(20 307–31 969) (229.88–397.96) (14.95–23.54) 
2004 24 723 287.30 18.66 
(20 027–31 510) (224.63–388.56) (15.12–23.78) 
2005 25 551 295.23 18.82 
(20 611–32 695) (230.06–399.37) (15.19–24.09) 
2006 24 744 282.42 18.80 
(20 033–31 451) (221.80–376.33) (15.22–23.90) 
2007 25 263 285.95 19.00 
(20 448–32 067) (225.07–378.37) (15.38–24.12) 
2008 24 759 278.07 19.04 
(19 984–31 452) (218.60–366.61) (15.37–24.19) 
2009 25 143 280.09 19.28 
(20 233–31 943) (219.81–368.03) (15.51–24.49) 
2010 25 035 275.99 19.19 
(20 206–31 901) (217.79–363.01) (15.49–24.45) 
2011 24 782 270.23 19.24 
(20 082–31 556) (214.71–354.09) (15.59–24.50) 
2012 24 913 269.08 19.25 
(20 255–31 735) (213.82–354.79) (15.65–24.52) 
2013 24 338 260.40 19.20 
(19 829–31 074) (207.69–343.73) (15.64–24.51) 
2014 24 263 256.18 19.21 
(19 889–30 907) (206.10–336.63) (15.75–24.47) 
* The values were generated for 100 000 persons and standardised for the age structure of the European 
population as recommended by Eurostat. 
Note. The brackets contain 95% confidence intervals.  
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Figure 4. Smoking-attributable and non-smoking-attributable standardised death rate, 2000–2014 
(with 95% confidence intervals) 
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3. Differences in smoking-attributable excess mortality  
by gender 
In the observed period, the absolute number of smoking-attributable excess mor-
tality of men decreased by 13% and amounted to 16 754 persons in 2014; the meas-
ure for women increased by more than one third, exceeding 7 500 at present. Conse-
quently, the percentage of men who died because of nicotine dependence within total 
mortality stagnated during one and a half decades, while that of women increased 
considerably, by 3.2 percentage points. About one in every four deaths of men (27%) 
and one in every ten deaths of women (12%) could be attributed to smoking in 2014.  
At the turn of the millennium, three and a half times more men died due to smok-
ing than women. The nicotine-dependence-related excess mortality rate of men com-
pared with that of women increased until 2003, then, because of a spectacular de-
cline, the difference fell by one third by the end of the observed period, decreasing 
significantly the gender gap. While the relevance of smoking to men’s general mor-
tality has fallen, the addiction of women, which was less important in the past, be-
came more substantial in the last one and a half decades. 
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Table 2 
Number of smoking-attributable excess deaths and their proportion within total mortality by gender,  
2000–2014 
Year  
Number of persons deceased due to smoking 
Percentage of 
men  women 
Men Women deceased due to smoking within total mortality 
2000 19 300 5 517 27.39 8.47 
(16 421–23 030) (3 932–8 138) (23.30–32.68) (6.04–12.50) 
2001 18 754 5 339 27.42 8.37 
(15 850–22 438) (3 825–7 986) (23.18–32.81) (6.00–12.52) 
2002 18 903 5 356 27.46 8.37 
(15 851–22 708) (3 852–8 148) (23.03–32.99) (6.02–12.73) 
2003 19 617 5 424 28.02 8.24 
(16 376–23 545) (3 931–8 424) (23.39–33.63) (5.97–12.80) 
2004 18 984 5 738 27.76 8.95 
(15 877–22 722) (4 151–8 789) (23.22–33.23) (6.47–13.71) 
2005 19 296 6 254 27.65 9.48 
(16 111–23 139) (4 501–9 556) (23.09–33.16) (6.82–14.49) 
2006 18 492 6 252 27.25 9.81 
(15 502–22 079) (4 531–9 372) (22.85–32.54) (7.11–14.70) 
2007 18 488 6 774 27.09 10.47 
(15 505–22 044) (4 942–10 023) (22.72–32.30) (7.64–15.49) 
2008 17 843 6 915 26.93 10.85 
(14 952–21 247) (5 032–10 205) (22.56–32.06) (7.89–16.01) 
2009 17 853 7 290 26.92 11.37 
(14 941–21 221) (5 292–10 723) (22.53–32.00) (8.26–16.73) 
2010 17 640 7 395 27.08 11.32 
(14 827–20 929) (5 378–10 972) (22.76–32.13) (8.23–16.80) 
2011 17 373 7 409 27.20 11.41 
(14 660–20 580) (5 422–10 977) (22.95–32.21) (8.35–16.91) 
2012 17 353 7 560 27.33 11.47 
(14 706–20 519) (5 549–11 215) (23.16–32.31) (8.42–17.01) 
2013 16 820 7 518 27.18 11.59 
(14 289–19 899) (5 539–11 175) (23.09–32.15) (8.54–17.22) 
2014 16 754 7 509 27.03 11.68 
(14 308–19 771) (5 582–11 135) (23.08–31.89) (8.68–17.31) 
Note. The brackets contain 95% confidence intervals.  
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Figure 5. Estimated proportion of smoking-attributable excess mortality within total mortality by gender, 2014 
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Figure 6. Smoking-attributable and non-smoking-attributable standardised death rate by gender, 2000–2014 
(with 95% confidence intervals) 
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Figure 7.  Smoking-attributable excess male mortality per 100 women, 2000–2014 
(with 95% confidence intervals) 
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4. Age structure of smoking-attributable excess mortality 
Examining the relative weight of each ten-year age group over 35 years, we can 
conclude that nicotine dependence requires more and more victims along with in-
creasing age. Between 2000 and 2014, smoking-attributable standardised death rate 
of both sexes declined significantly in the 35–44 and 45–54 age groups: by 63% in 
the younger and by 44% in the older age group of men and by 67% and 15% respec-
tively for women. By contrast, the rate grew significantly (by 56%) in the case of 
older, 55–64-year-old women. After one and a half decades, the gender differences, 
apart from the 35–44 age group, became considerably smaller in all ages, especially 
in the age over 85 years. (See Figure 9.) In 2014, these differences increased by the 
progress of age and grew from about three-fold in the age group of 35–64 to nearly 
four-fold over 65 years of age. In the reference period, the decline in smoking-
attributable excess mortality was the largest in the 35–54 age group of both sexes. 
(See Figure 9.) In ages over 54, this figure was above 1 for men and below 1 for 
women, which means that the extent of smoking-attributable mortality of men de-
creased and that of women increased between 2000 and 2014. 
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Figure 8. Smoking-attributable standardised death rate by gender and age group, 2000 and 2014 
(with 95% confidence intervals) 
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Figure 9. Smoking-attributable excess mortality by age group 
(estimates) 
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Table 3 
Smoking-attributable standardised death rate per 100 000 persons by gender and age group, 2000 and 2014 
Year 
35–44 45–54 55–64 65–74 75–84 85– Total 
year-old 
 
men 
2000 110.1 404.2 880.9 1681.6 2096.4 4464.8 606.6 
(103.2–116.1) (377.9–427.9) (798.7–957.6) (1462.0–1898.8) (1588.4–2757.1) (2627.2–8264.9) (489.6–781.1) 
2014 40.2 226.6 749.3 1357.5 1745.0 2763.2 456.1 
(36.7–43.5) (205.4–246.3) (688.5–805.9) (1190.0–1521.1) (1350.1–2230.2) (1785.9–4700.1) (377.3–563.5) 
 
women 
2000 41.6 106.9 171.3 328.2 355.4 393.5 109.6 
(38.8–44.2) (98.1–115.2) (143.0–201.9) (233.6–449.2) (184.5–650.0) (109.3–1207.7) (76.3–167.1) 
2014 13.6 91.1 267.0 390.8 407.7 680.2 132.6 
(12.1–15.1) (84.0–97.8) (244.2–289.0) (324.6–465.1) (231.4–681.6) (203.2–2138.2) (98.2–198.5) 
Note. The brackets contain 95% confidence intervals. 
5. Causes of death structure of smoking-attributable excess 
mortality2 
In respect of public health, not only the age of a deceased smoker is an important 
issue but also the cause why the death has occurred. The latter can be analysed by the 
structure of the causes of death, the change of which is basically influenced by two 
factors: 1. What progress has been made in medical science over the period in terms 
of curing and preventing a disease leading to death; 2. How the number of persons in 
the various age groups exposed to the possible cause of death (in other words, the 
age structure of the population) has changed.  
In 2014, the most smoking-attributable deaths of men, a total of 4 702, were 
caused by malignant neoplasms of the trachea, bronchus and lung. Ischaemic heart 
diseases are the second in the ranking with a similar value, followed by other malig-
nant neoplasms as well as bronchitis, emphysema and COPD (chronic obstructive 
pulmonary disease) at a lower level. A more than 30% increase can be observed in 
 
2 The method of processing causes of death data was changed in 2005. Manual coding has been replaced by 
automated processing in which the coding of diagnose texts and the selection among underlying causes are 
carried out by a software. Therefore, there are breaks in the time series of causes-of-deaths data between 2004 
and 2005. 
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mortality from the last four illnesses between 2000 and 2014, and by now their abso-
lute number have reached the number of 2 342 of other malignant neoplasms.  
Among women, trachea, bronchus and lung cancers were also the most danger-
ous, altogether 2 378 women died from these diseases due to their nicotine depend-
ence. They were followed by ischaemic heart diseases, bronchitis, emphysema, 
COPD and other malignant neoplasms. In 2014, 44% more women died of malignant 
neoplasms of the trachea, bronchus and lung and twice as many (numerically 1 352) 
smoking women deceased due to bronchitis, emphysema and COPD than at the turn 
of the millennium.   
Figure 10. Absolute numbers of smoking-attributable excess mortality by gender and cause  
of death, 2000 and 2014 
(with 95% confidence intervals) 
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same weight and by ischemic heart diseases. Compared with the turn of the millenni-
um, the relative relevance of each disease category associated with this harmful ad-
diction has increased among men at the expense of other diseases. In the case of 
women, trachea, bronchus and lung cancers are responsible for one in every three 
smoking-attributable deaths. Note that the relative relevance of this dangerous dis-
ease group has increased by 7.7 percentage points since 2000. In contrast, ischemic 
heart diseases are responsible for one in every four tobacco-related deaths of women, 
and their relative importance has decreased by 3 percentage points since the turn of 
the millennium. Smoking-related mortality due to bronchitis, emphysema and COPD 
should be also mentioned as the relative relevance of these diseases showed a spec-
tacular increase for both sexes in the last one and a half decades.  
Table 4 
Distribution of the estimated value of the standardised death rate per 100 000 persons by gender  
and cause of death, 2000 and 2014 
(percentage) 
Year 
Malignant 
neoplasms of the 
trachea, bron-
chus and lung 
Ischaemic heart 
diseases 
Other malignant 
neoplasms 
Bronchitis, 
emphysema, 
COPD 
Other diseases Total 
 
Men 
2000 23.3 25.7 12.7 8.3 30.0 100.0 
2014 26.1 26.0 13.5 11.5 22.9 100.0 
 
Women 
2000 23.9 27.0 8.3 11.1 29.7 100.0 
2014 31.6 24.0 8.8 15.9 19.7 100.0 
In 2014, trachea, bronchus and lung cancers as well as ischaemic heart diseases 
were responsible for 52% of smoking-attributable excess mortality among men and 
for 56% among women. This justifies the detailed analysis of these two disease cate-
gories by gender, time series and age group. Another aim of this part of the research 
is to present the very different epidemiological nature of trachea, bronchus and lung 
cancers and ischaemic heart diseases. 
Between 2000 and 2014, the smoking-attributable standardised death rate due to 
malignant neoplasms of the trachea, bronchus and lung per 100 000 persons fell by 
16% (with interruptions) for men and grew considerably, by 60% for women (the 
increase was continuous). The decrease in the age-specific rate of the 35–75 age 
group of men per 100 000 persons has contributed primarily to the decline, and the 
mortality of 50–70-year-old women caused by their alarmingly increasing nicotine 
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addiction has been in the background of the high rise observed. About nine in every 
ten deaths of men due to lung cancer are related to smoking; the corresponding figure 
of women is less than 6-8. Between 2000 and 2014, this measure improved consider-
ably among 35–50-year-old men and 35–45-year-old women. However, the opposite 
is true for 55–65-year-old, middle-aged women: the proportion of their smoking-
attributable excess mortality showed a significant increase in deaths caused by ma-
lignant neoplasms of the trachea, bronchus and lung.  
Figure 11. Smoking-attributable standardised death rate due to malignant neoplasms of the trachea,  
bronchus and lung per 100 000 persons by gender, 2000–2014 
(with 95% confidence intervals) 
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In the reference period, smoking-attributable death rate due to ischaemic heart 
diseases per 100 000 persons, fell by 24% among men and rose by 7% among wom-
en. For the latter, the indicator peaked around 2010, and since then a slight decrease 
has been observed. In the case of men, the significant decline was owing to the mod-
erate smoking of the 35–65-year-olds, while the age-specific indicator of women 
rose considerably only among the 60–65-year-olds. Examining the proportion of 
smoking-attributable excess mortality in deaths caused by ischaemic heart diseases, 
we can conclude that generally fewer deaths can be associated with smoking than in 
the case of trachea, bronchus and lung cancers. As for smoking-related lung cancer, 
the value of the indicator improved significantly among men aged 35–50 years and 
women aged 35–45 years between 2000 and 2014. However, the 55–65 female age 
group is more affected nowadays by smoking-attributable mortality due to ischaemic 
heart diseases than at the turn of the millennium.   
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Figure 12. Age-specific smoking-attributable excess mortality caused by malignant neoplasms of the trachea, 
bronchus and lung per 100 000 persons by gender and age group, 2000 and 2014 
(with 95% confidence intervals) 
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Figure 13. Proportion of smoking-attributable excess mortality in deaths caused  
by malignant neoplasms of the trachea, bronchus and lung in the population aged 35 years  
and over by gender and age group, 2000 and 2014 
(with 95% confidence intervals) 
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Figure 14. Smoking-attributable standardised death rate due to ischaemic heart diseases  
per 100 000 persons by gender, 2000–2014 
(with 95% confidence intervals) 
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Figure 15. Age-specific smoking-attributable excess mortality caused by ischaemic heart diseases  
per 100 000 persons by gender and age group, 2000 and 2014 
(with 95% confidence intervals) 
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The detailed analysis of smoking-attributable trachea, bronchus and lung cancers 
as well as ischaemic heart diseases by gender, time series and age group reveals the 
very different epidemiological nature of these disease groups, too.   
1. Naturally, smoking plays a role in a larger part of deaths caused 
by lung cancer than in deaths due to ischaemic heart diseases.  
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2. Nicotine-consumption-related, malignant neoplasms of the lung 
develop and lead to death at a younger age, therefore, they are faster in 
progression, spread and more aggressive than ischaemic heart diseases. 
3. It is similar in both causes of death that the proportion of tobac-
co-related mortality within total mortality is generally higher in 
younger ages than among the elderly. Thus, the role of smoking in ear-
ly mortality is significant, and – especially through lung cancer – re-
sults in a considerable number of years of life lost.  
Figure 16. Proportion of smoking-attributable excess mortality in deaths caused by ischaemic heart diseases in 
the population aged 35 years and over by gender and age group, 2000 and 2014 
(with 95% confidence intervals) 
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6. Years of life lost attributable to smoking 
Mortality conditions can be characterised not only by (smoking) specific death 
rates but also by derived indicators. Besides life expectancies, such an indicator used 
in statistics is the potential years of life lost, which sums up the (not lived) lifetimes 
of persons deceased in a certain population group until a fixed age. The selection of 
age limits is optional, the present study analyses two of them: the 70 years of age 
used in international practice, and the life expectancy at the age of death. If someone 
dies, for example, at the age of x, then the number of years of life lost is 70 – x in 
case x < 70, while if he/she dies at the age of 70 or over, the indicator is 0 (KSH 
[2014] p. 22.). Due to the methodology used in the research, the number of smoking-
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attributable excess deaths is known by age group, which allows the examination of 
years of life lost. 
Table 5 
Indicators of years of life lost from the potential 70 years by gender, 2000 and 2014  
Year 
Absolute number of those 
deceased attributable to 
smoking under 70 years 
of age 
Smoking attributable 
death rate within total 
mortality under 70 years 
of age (%) 
Absolute number of years 
of life lost attributable to 
smoking  from the 
potential 70 years 
Standardised* years of 
life lost attributable to 
smoking from the poten-
tial 70 years per 100 000 
persons 
 
Men 
2000 
11 113 29.9 129 950 2 824 
(10 124–12 038) (27.3–32.4) (120 321–138 777) (2 608–3 023) 
2014 
9 398 25.3 89 640 1 843 
(8 554–10 187) (23.0–27.4) (81 872–96 864) (1 682–1 992) 
 
Women 
2000 
2 904 15.6 38 120 725 
(2 444–3 425) (13.1–18.4) (34 095–42 263) (648–805) 
2014 
3 974 21.3 37 267 685 
(3 584–4 358) (19.2–23.4) (34 023–40 392) (626–742) 
* The values were generated for 100 000 persons and standardised for the age structure of the European 
population as recommended by Eurostat. 
Note. The brackets contain 95% confidence intervals. 
Since 2000, 1 715 fewer men and 1 070 more women younger than 70 years of 
age have died due to smoking, and as a result, the number of the former was 9 398 
and that of the latter amounted to 3 974 in 2014. While the proportion of smoking-
attributable deaths within total mortality of men under the age of 70 declined sharply 
in the reference period, it grew considerably among women. Nevertheless, the abso-
lute number of years of life lost by women decreased between 2000 and 2014, which 
means that the age at smoking-attributable death shifted more and more to older age 
groups losing fewer years of life and approached 70 years.   
Figure 17 shows the standard values of years of life lost from the potential 
70 years per 100 000 persons by gender and cause of death for 2000 and 2014. The 
more than twenty causes of death attributable to smoking are combined in one cate-
gory. This shares a common set with different groups, e.g. lung cancer with malig-
nant neoplasms and ischaemic heart diseases with diseases of the circulatory system. 
However, this duplication is not a problem if we want to draw attention to the num-
ber of years of life lost due to smoking, since it outlines the magnitude of smoking-
attributable premature excess mortality compared with other main groups of causes 
of death (KSH [2014] p. 37.).   
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Figure 17. Standardised years of life lost from the potential 70 years, per 100 000 persons  
by gender and cause of death, 2000 and 2014 
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Note. For smoking-attributable diseases, the figure shows the 95% confidence intervals, too. 
As far as years of life lost are concerned, the ranking of the main groups of causes 
of deaths is similar for both genders. Nowadays, most years of life are lost due to 
malignant neoplasms. These are followed by the diseases of the circulatory system 
and not much lagging behind, by the smoking-attributable excess deaths on the third 
place. It is noteworthy that nicotine dependence alone results in significantly more 
years of life lost than external causes of death (KSH [2014] p. 37.). It should be em-
phasised though that the extent of smoking-attributable premature mortality fell sig-
nificantly among men in the past one and a half decades. Among women, however, 
premature mortality due to malignant neoplasms (including deaths caused by lung 
cancer) has increased notably.   
If we compare the years of life lost not to 70 years of age but to life expectancies in 
different age groups, we can examine older ages as well. In all age groups of men un-
der the age of 55, the number of years of life lost attributable to smoking decreased 
considerably in the examined period. An important development was in 2014 that the 
50–54 age group was a “watershed” among women compared with 2000. The indicator 
of years of life lost attributable to smoking compared with life expectancy per 
100 000 persons by age group fell significantly under this age and increased considera-
bly above this until 70 years of age.  
Smoking-attributable diseases 
All other diseas s 
External causes of death 
Diseases of the digestive system 
Diseases of the respiratory system 
Diseases of the circulatory system 
Malignant neopl sms
Infectious diseases
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Figure 18. Years of life lost attributable to smoking compared with life expectancy, per 100 000 persons  
by gender and age group, 2000 and 2014 
(with 95% confidence intervals) 
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7. International outlook 
The WHO-HFA database provides an opportunity for the international compari-
son of smoking-attributable mortality. Contrary to the methodology applied in this 
study, the indicator in the database significantly overestimates the real values due to 
its different calculation method.3 This chapter provides information on countries with 
similar culture, historical background and geographic features in the Central Europe-
an region.  
 
3 “SDR, selected smoking-related causes, per 100 000. Indicator code: E991722.T  
SDR is the age-standardised death rate calculated using the direct method, i.e. represents what the crude 
rate would have been if the population had the same age distribution as the standard European population).  
The mortality from combined, selected causes of death which are known from literature to be related to 
smoking. It has to be pointed out that it is a relatively rough indicator and it is NOT the estimate of tobacco-
attributable mortality, which is more complex and difficult to calculate.  
This simple pooling of smoking-related deaths (irrespective of what is the actual proportion of deaths due 
to tobacco in each cause) can help to better rank countries by smoking-related mortality and can be used to  
better track trends in deaths associated with tobacco than would be possible by using separate causes.” (See 
https://gateway.euro.who.int/en/indicators/hfa_296-1980-sdr-selected-smoking-related-causes-per-100-000/) 
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Figure 19. Smoking-attributable standardised death rate per 100 000 persons by gender and country, 2013, 
and its change by gender and country, 2000–2014 
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* 2012 data. 
** 2010 data. 
Source: WHO-HFA database (http://data.euro.who.int/hfadb/). 
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By smoking-attributable mortality, these countries can be divided into three 
groups. Austria and Poland are in the first category where the value of this indicator 
is the lowest. The Czech Republic, Croatia and Bulgaria are in the second while 
Romania, Hungary and Slovenia are in the third group with the highest values. In the 
last one and a half decades, regardless of gender, the value of the smoking-
attributable standardised death rate decreased significantly in each country, but the 
rate of decline was different. Among the countries of the region, except for Slovenia, 
the rate of mortality due to smoking fell to the smallest extent in Hungary. The lag-
ging behind is especially high in the case of women: while the value of the indicator 
fell by only about 15% between 2000 and 2013 in Hungary, the decrease was ap-
proximately 40% in Poland. The situation in Austria is considered exemplary be-
cause the country has the lowest rate of smoking-attributable mortality in the Central 
European region and has experienced one of the strongest declines of this indicator 
since 2000, regardless of gender.   
8. Summary 
The aim of the research was to quantify the effect of smoking on mortality condi-
tions between 2000 and 2014 in Hungary. One in every two men and one in every 
three women in Hungary is affected by nicotine addiction. It is good news that over 
one and a half decades, the number of smokers and ex-smokers (i.e. the base popula-
tion of smoking-attributable excess mortality) has decreased among both sexes. How-
ever, a disadvantageous development is that the proportion of nicotine addicts among 
older women aged 55–65 has increased significantly since 2000, and no decrease can 
be observed in the smoking prevalence of the 18–30-year-old population. Approxi-
mately one in every five deceased persons dies due to smoking every year in Hungary. 
Since the turn of the millennium, the smoking-attributable standardised death rate has 
fallen considerably in the 35–54 age group of both genders, while it has increased 
significantly in the 55–64 age group of women. The detailed examination of the caus-
es of death structure revealed that chronic diseases, i.e. malignant neoplasms (espe-
cially lung cancer) and the diseases of the circulatory system, are the most dangerous 
for smokers and ex-smokers of both genders. At the same time, the very different 
epidemiological nature of smoking-attributable trachea, bronchus and lung cancers 
and ischaemic heart diseases is revealed, too: malignant neoplasms develop and lead 
to death at a younger age, therefore, they are faster in progression and are more ag-
gressive than ischaemic heart diseases. In this respect, the situation of smoking wom-
en is especially alarming: the smoking-attributable standardised death rate due to 
trachea, bronchus and lung cancers per 100 000 women grew drastically, by 60% (!) 
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between 2000 and 2014. It is explained by the worsening mortality rate of 50–70-
year-old women that is caused by their increasing nicotine dependence, which has had 
an adverse effect on their premature mortality as well. “The accelerating emancipa-
tion, the blurring difference between gender roles, and thus, the increasing level of 
stress, in other words, the »masculinising« lifestyle of women may be the background 
to this. At the same time, the higher extent of premature mortality of men and the 
phenomenon of divorces can fundamentally change the family bonds of middle-aged 
women.” (KSH [2014] p. 40.) There is a pressure to cope with these changes, which 
may cause that the affected persons increase the consumption of tobacco and alcohol, 
even if it is self-destructive. In addition, the examination of years of life lost revealed 
that the relevance of smoking-related diseases has overtaken that of external causes of 
death for both genders. Due to the magnitude of excess mortality caused by this addic-
tion, smoking has had a significant impact on Hungary’s mortality from the turn of the 
millennium until now. Nicotine dependence has considerably slowed down the 
downward trend in mortality between 2000 and 2014; its contribution to the natural 
decrease was determinant (KSH [2014] p. 38.). In the past one and a half decades, this 
addiction claimed more than 370 thousand lives in Hungary. It should be stressed that 
there is still a lot to be done in the field of improving smoking-attributable mortality 
conditions in Hungary, which is also proven by the fact that, according to the interna-
tional outlook, the lagging behind of Hungary is significant compared with the other 
countries of the region. 
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